Prevention and treatment of osteoporosis in women: an update

Obstetrics, Gynaecology and Reproductive Medicine

Volumn 19, Issue 6, 2009, Pages 157-163

  Brixen, Kim ^a,b   Kassem, Moustapha ^a,b   Abrahamsen, Bo ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

osteoporosis; postmenopausal; prevention; review; therapy

Indexed keywords

ACTIVIN ANTIBODY; ALENDRONIC ACID; ANTIBODY; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CALCIUM SENSING RECEPTOR; CHLORIDE CHANNEL; COLECALCIFEROL; DENOSUMAB; DICKKOPF 1 ANTIBODY; ESTROGEN; ETIDRONIC ACID; GESTAGEN; GLUCAGON LIKE PEPTIDE 2; GROWTH HORMONE; IBANDRONIC ACID; ODANACATIB; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RISEDRONIC ACID; SCLEROSTIN ANTIBODY; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; STRONTIUM RANELATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D; VITAMIN K GROUP; ZOLEDRONIC ACID;

ABDOMINAL PAIN; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; COLON CANCER; COST EFFECTIVENESS ANALYSIS; CREATINE KINASE BLOOD LEVEL; DIARRHEA; DIZZINESS; DYSPEPSIA; EOSINOPHILIA; EXERCISE; FALLING; FRAGILITY FRACTURE; HEADACHE; HEARTBURN; HIP; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; LEG CRAMP; LIFESTYLE MODIFICATION; MAGNESIUM BLOOD LEVEL; MOTIVATION; MUSCULOSKELETAL DISEASE; NAUSEA; OSTEOPOROSIS; POSTMENOPAUSE; PROPHYLAXIS; RASH; RECOMMENDED DRUG DOSE; RISK; SIDE EFFECT; SMOKING CESSATION; SYSTEMIC DISEASE; THROMBOEMBOLISM; URIC ACID BLOOD LEVEL; VAGINAL DRYNESS; WOMEN'S HEALTH;

EID: 66149165725     PISSN: 17517214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogrm.2009.03.001     Document Type: Article

References (15)

1. M. Kassem K. Brixen L. Mosekilde Ageing of the human skeleton and its contribution to osteoporotic fractures R. Aspinall Ageing of organs and systems 2003 Kluwer Academic Publishers The Netherlands
2. E. Seeman Pathogenesis of bone fragility in women and men Lancet 359 2002 1841 1850
3. A. Avenell W.J. Gillespie L.D. Gillespie D. O’Connell Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis Cochrane Database Syst Rev 2005 (3): CD000227
4. H.A. Bischoff-Ferrari Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomised controlled trials Am J Clin Nutr 86 2007 1780 1790
5. V. Beral Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
6. J.E. Rossouw Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial JAMA 288 2002 321 333
7. B. Ettinger Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 282 1999 637 645
8. S.R. Cummings Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 280 1998 2077 2082
9. K.W. Lyles Zoledronic acid and clinical fractures and mortality after hip fracture N Engl J Med 357 2007 1799 1809
10. M.R. McClung Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group N Engl J Med 344 2001 333 340
11. P.J. Meunier The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 2004 459 468
12. J.Y. Reginster Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2005 2816 2822
13. R.M. Neer Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 2001 1434 1441
14. P.M. Christensen K. Brixen I.S. Kristiansen Danish Osteoporosis Outcome Model (DOOM) 2003 University of Southern Denmark (Department of Health Economics)
15. C. Deal Potential new drug targets for osteoporosis Nat Clin Pract Rheumatol 5 2009 20 27